Tuesday, December 30, 2014
FDA Approves BioCryst Flu Treatment
Durham's biotech company BioCryst has had its flu treatment, RAPIVAB approved by the FDA.
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment